Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry - 1 Jan 2012

Hong Chen-Jee, Chen Tzu-Ting, Bai Ya Mei, Liou Ying-Jay, Tsai Shih-Jen

Abstract excerpt

OBJECTIVES: Schizophrenic patients treated with clozapine or olanzapine often develop hypertriglyceridemia. The apolipoprotein A5 gene (APOA5), which affects VLDL production and lipolysis, has been implicated in the triglyceride (TG) metabolism. This study examined the association of common APOA5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Apolipoprotein A-V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins A

Share to Benzodiazepines

Share to Clozapine

Share to Hypertriglyceridemia

Share to Olanzapine

Share to Risperidone

Source

Identifiers

PMID: 21375366
DOI: 10.3109/15622975.2010.551543

Genes

APOA5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21375366-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.PMID 21375366Read ↗

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.Semantic proximity Read ↗

Genetic variants of microsomal triglyceride transfer protein (MTTP) are associated with metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.Semantic proximity Read ↗

Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.Semantic proximity Read ↗

APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.Semantic proximity Read ↗

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.Semantic proximity Read ↗

Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.Semantic proximity Read ↗

A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese.Semantic proximity Read ↗

Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.Semantic proximity Read ↗

Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.Semantic proximity Read ↗

Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.Semantic proximity Read ↗

Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.Semantic proximity Read ↗

Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.